Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Psychopharmacol. 2016 Sep 27;31(1):17–30. doi: 10.1177/0269881116668590

Table 1.

Demographics, drug use, and comorbid psychiatric characteristics by group.

METH+ (n=17) METH− (n=23)
Characteristic Mean +/− SD Mean +/− SD Statistics a
Age at scan (years) 38.0 ± 8.7 38.0 ± 11.9 t(38)=0.00, p=1.00, g=0.00
Years of education 12.1 ± 2.0 14.4 ± 2.2 t(36.49)=−3.50, p<0.001, g=−1.1
Wide Range Achievement Test-4 standard score 100.8 ± 10.5 108.1 ± 13.4 t(37.85)=−1.94, p=0.06, g=−0.6
Beck Depression Inventory (at scan) 13.9 ± 8.9 2.0 ± 3.3 t(19.25)=5.25, p<0.001, g=1.7
Profile of Mood States (at scan) 72.6 ± 34.1 57.1 ± 15.9 t(21.15)=1.74, p=0.10, g=0.6
Fagerström Test of Nicotine Dependence Total 3.5 ± 3.3 1.3 ± 2.3 t(26.84)=2.30, p=0.03, g=0.7
% Male 100% 87% χ2(n=1)=0.89, p=0.35
% Right-handed 94% 96% χ2(n=1)=0.00, p=1.00
% White 59% 70% χ2(n=2)=3.36, p=0.19
% Latino 18% 26%
% African-American 24% 4%
% Scanned on 3T General Electric MR750 system 35% 57% χ2(n=1)=1.02, p=0.31
Antisocial personality disorder (lifetime) 53% 9% χ2(n=1)=7.51, p=0.01
Attention-deficit/hyperactivity disorder (lifetime) 29% 0% χ2(n=1)=5.28, p=0.02
Major depressive disorder (lifetime) 47% 17% χ2(n=1)=2.81, p=0.09
Tobacco use (current) 43% 14% χ2(n=1)=6.24, p=0.01
Alcohol dependence (lifetime) 35% 13% χ2(n=1)=1.65, p=0.20
Cannabis dependence (lifetime) 29% 0% χ2(n=1)=3.68, p=0.05
Cocaine dependence (lifetime) 41% 0% χ2(n=1)=8.80, p<0.01
Opiate dependence (lifetime) 5% 0% χ2(n=1)=0.02, p=0.88
Lifetime methamphetamine use in grams 2461 ± 2954 N/A
Lifetime methamphetamine use in days 1913 ± 1551 N/A
Age of first methamphetamine use (years) 25.4 ± 8.6 N/A
Days since last methamphetamine use 173 ± 160 N/A
Primary route of methamphetamine use Smoking N/A
a

Statistical comparisons were by means of Welsh t-tests or χ2 tests for equality of proportions, and Hedge’s g to report effect sizes.

This assessment was completed only in participants who endorsed current use of tobacco.

Two METH+ and 3 METH− participants did not report current levels of tobacco use.